Streetbeat News

Stock Prices

BGNE

Over the past 3 months, 7 analysts have published their opinion on BeiGene (NASDAQ:BGNE) stock. The majority of the ratings are bullish or somewhat bullish. The average 12-month price target for BeiGene is $270.71, a decrease of 14.78% from the previous average price target of $317.67.

Portfolio Pulse from Benzinga Insights

September 12, 2023 | 3:00 pm

BNBUSD

BNB's price has increased by 3.03% over the past 24 hours to $211.77, diverging from its trend over the past week where it experienced a 1.0% loss. The trading volume for the coin has risen 91.0% over the past week while the circulating supply has decreased 0.28% to 153.86 million, making up an estimated 76.93% of its max supply of 200.00 million. BNB's current market cap ranking is #4 at $32.61 billion.

Portfolio Pulse from Benzinga Insights

September 12, 2023 | 3:00 pm

ANET

Arista Networks (NYSE:ANET) has outperformed the market over the past 5 years by 14.65% on an annualized basis, producing an average annual return of 23.73%. If an investor had bought $1000 of ANET stock 5 years ago, it would be worth $2,831.93 today.

Portfolio Pulse from Benzinga Insights

September 12, 2023 | 3:00 pm

BDX

Becton Dickinson (NYSE:BDX) has outperformed the market over the past 20 years by 2.75% on an annualized basis, producing an average annual return of 10.33%. If an investor had bought $100 of BDX stock 20 years ago, it would be worth $726.06 today.

Portfolio Pulse from Benzinga Insights

September 12, 2023 | 3:00 pm

CTAS

Over the past 3 months, 7 analysts have published their opinion on Cintas (NASDAQ:CTAS) stock. The average 12-month price target for Cintas is $530.29, with a high of $580.00 and a low of $441.00. This average price target has increased by 5.94% over the past month.

Portfolio Pulse from Benzinga Insights

September 12, 2023 | 3:00 pm

BTCUSD

Bitcoin's price has risen 3.77% to $26,108.00 in the past 24 hours, continuing its positive trend over the past week with a 2.0% gain. The trading volume for the coin has risen 123.0% over the past week, diverging from the circulating supply of the coin, which has decreased 0.36%. The current market cap ranking for BTC is #1 at $509.07 billion.

Portfolio Pulse from Benzinga Insights

September 12, 2023 | 3:00 pm

VTRO

Vitro Biopharma, Inc (NASDAQ:VTRO) is set to start trading on the NASDAQ exchange under the ticker VTRO on September 13. The company is offering shares at an expected price between $5.00 and $6.00 per share with an insider lock-up period of 180 days ending on March 11, 2024. Vitro Biopharma is a biotechnology company targeting autoimmune diseases and inflammatory disorders.

Portfolio Pulse from Benzinga Insights

September 12, 2023 | 3:00 pm

DTCK

Davis Commodities Limited (NYSE:DTCK) is set to IPO on September 13, with shares expected to be priced between $4.00 and $4.50. The company, an agricultural commodity trading firm based in Singapore, will have an insider lock-up period of 180 days ending on March 11, 2024.

Portfolio Pulse from Benzinga Insights

September 12, 2023 | 3:00 pm

NTRS

Northern Trust's shares are trading lower as the company presents at the Barclays Global Financial Services Conference.

Portfolio Pulse from Benzinga Newsdesk

September 12, 2023 | 3:00 pm

CRNX

Crinetics Pharmaceuticals, Inc. (NASDAQ:CRNX) shares are trading higher after the company announced positive results from its Phase 3 PATHFNDR-1 study of investigational compound paltusotine. The company also announced a $250 million public offering of its common stock, with an additional $37.5 million option for underwriters. The proceeds will be used to fund the development of paltusotine and other R&D programs.

Portfolio Pulse from Erica Kollmann

September 12, 2023 | 2:56 pm